Evidence that enteroglucagon (II) is identical with the C-terminal sequence (residues 33-69) of glicentin
- PMID: 7165698
- PMCID: PMC1153876
- DOI: 10.1042/bj2070381
Evidence that enteroglucagon (II) is identical with the C-terminal sequence (residues 33-69) of glicentin
Abstract
Enteroglucagon (II) was isolated from extracts of pig ileum mucosa by repeated gel filtrations, and its immunochemical and chromatographic characteristics were compared with those of a synthetic peptide corresponding to the 33-69 sequence of pig glicentin, before and after digestion with trypsin or trypsin followed by carboxypeptidase B, by using five region-specific assays covering most of the glicentin sequence. Enteroglucagon (II) and the synthetic peptide behave identically under three different conditions of chromatography as determined with all five assays (including a highly specific radioreceptor assay), and gave rise to similar fragments after enzyme digestion. It was therefore concluded that enteroglucagon (II) and the 33-69 sequence of glicentin are most probably identical.
Similar articles
-
Evidence that glicentin contains the entire sequence of glucagon.Biochem J. 1980 May 1;187(2):337-43. doi: 10.1042/bj1870337. Biochem J. 1980. PMID: 6893148 Free PMC article.
-
The biological significance of "enteroglucagon." Present status.Peptides. 1986;7 Suppl 1:37-42. doi: 10.1016/0196-9781(86)90161-0. Peptides. 1986. PMID: 3529053 Review.
-
The primary structure of porcine glicentin (proglucagon).Regul Pept. 1981 May;2(2):139-50. doi: 10.1016/0167-0115(81)90007-0. Regul Pept. 1981. PMID: 6894800
-
Purification and sequence of rat oxyntomodulin.Proc Natl Acad Sci U S A. 1994 Sep 27;91(20):9362-6. doi: 10.1073/pnas.91.20.9362. Proc Natl Acad Sci U S A. 1994. PMID: 7937770 Free PMC article.
-
Enteroglucagon.Annu Rev Physiol. 1997;59:257-71. doi: 10.1146/annurev.physiol.59.1.257. Annu Rev Physiol. 1997. PMID: 9074764 Review.
Cited by
-
Pharmacokinetic, insulinotropic, and glucagonostatic properties of GLP-1 [7-36 amide] after subcutaneous injection in healthy volunteers. Dose-response-relationships.Diabetologia. 1995 Jun;38(6):720-5. doi: 10.1007/BF00401846. Diabetologia. 1995. PMID: 7672496 Clinical Trial.
-
Exaggerated glucagon-like peptide-1 and blunted glucose-dependent insulinotropic peptide secretion are associated with Roux-en-Y gastric bypass but not adjustable gastric banding.Surg Obes Relat Dis. 2007 Nov-Dec;3(6):597-601. doi: 10.1016/j.soard.2007.08.004. Epub 2007 Oct 23. Surg Obes Relat Dis. 2007. PMID: 17936091 Free PMC article.
-
Endogenous glucose production increases in response to metformin treatment in the glycogen-depleted state in humans: a randomised trial.Diabetologia. 2015 Nov;58(11):2494-502. doi: 10.1007/s00125-015-3733-2. Epub 2015 Aug 14. Diabetologia. 2015. PMID: 26271344 Clinical Trial.
-
Proglucagon products in plasma of noninsulin-dependent diabetics and nondiabetic controls in the fasting state and after oral glucose and intravenous arginine.J Clin Invest. 1991 Feb;87(2):415-23. doi: 10.1172/JCI115012. J Clin Invest. 1991. PMID: 1991827 Free PMC article.
-
Circulating glucagon after total pancreatectomy in man.Diabetologia. 1983 Nov;25(5):396-9. doi: 10.1007/BF00282517. Diabetologia. 1983. PMID: 6653943
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources